Css LLC Macrogenics Inc Put Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $972,287 - $1.7 Million	-51,200 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $168,867 - $226,200	-8,700 Reduced 14.52%	51,200 $1.17 Million
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $409,854 - $524,560	16,600 Added 38.34%	59,900 $1.51 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $225,160 - $1.26 Million	43,300 New	43,300 $1.21 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.